03.10.2016
- Israel’s Teva Pharmaceutical Industries has launched a generic equivalent of British drugmaker GlaxoSmithkline’s Epzicom (abacavir and lamivudine) 600 mg/300 mg tablets in the US...
09.08.2016
- Israel’s Teva Pharmaceutical Industries has agreed to buy Allergan’s generics distributer Anda for $500 million. Anda distributes generic, branded, specialty and over-the-counter...
29.07.2016
- Israel’s Teva Pharmaceutical Industries has been cleared by the US Federal Trade Commission (FTC) to proceed with its purchase of Allergan’s generics business after agreeing to...
12.05.2016
- The good old days are gone — at least with regard to simplicity in business life. This is particularly true for life sciences companies affected by trends increasing the complexity...
11.05.2016
- Israel-based Teva, the world's largest generic drugmaker, still expects its $40.5 billion acquisition of Allergan's generics business, which trades as Actavis, to close in June...
07.04.2016
- The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...
11.03.2016
- As mooted earlier in the week, the European Commission (EC) has given its approval for Israel-based Teva’s planned $40.5 billion acquisition of the generics arm of Ireland...
15.02.2016
- Major UK drugs firm GlaxoSmithKline (GSK) has been fined more than £37 million by the Competition and Markets Authority (CMA) for anti-competitive behavior relating to generic...
